Live Breaking News & Updates on Nasdaq Mygn

Stay updated with breaking news from Nasdaq mygn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myriad Genetics Chief Financial Officer Bryan Riggsbee

SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today. ....

United States , Paulj Diaz , Glenn Farrell , Bryan Riggsbee , Matt Scalo , Genetics Inc , Yale University , Emory University , Exchange Commission , Clover Health , Sotera Health , Prior To Clover Health , Scott Leffler , Chief Financial Officer , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Quarterly Reports , Current Reports , Myriad Genetics , Nasdaq Mygn , Myriad Genetics ,

Artisan Partners Limited Partnership Raises Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)

Artisan Partners Limited Partnership increased its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 15.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,538,065 shares of the company’s stock after purchasing an additional 331,207 shares during the […] ....

United States , Richard Bryan Riggsbee , Envestnet Asset Management Inc , Jpmorgan Chase Co , Artisan Partners Limited Partnership , Genetics Company Profile , Genetics Inc , Securities Exchange Commission , Beverly Hills Private Wealth , Swiss National Bank , Commonwealth Of Pennsylvania Public School Empls Retrmt , Earnest Partners , Goldman Sachs Group , Myriad Genetics , Free Report , Partners Limited Partnership , Hills Private Wealth , National Bank , Pennsylvania Public School Empls Retrmt , Envestnet Asset Management , Asset Management , Get Free Report , Bryan Riggsbee , Exchange Commission , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test ,

Myriad Genetics Announces Pricing of Upsized Offering of

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing. ....

New York , United States , Glenn Farrell , Matt Scalo , Morgan Stanley , Company Quarterly Reports On Form , Company Annual Report On Form , Wells Fargo Securities , Company Or Myriad Genetics , Goldman Sachs Co , Prospectus Department , Exchange Commission , Genetics Inc , Myriad Genetics , Securities Litigation , Goldman Sachs , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Nasdaq Mygn , Myriad Genetics ,

Myriad Genetics Announces Proposed Offering of $100 Million

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing. ....

New York , United States , Glenn Farrell , Matt Scalo , Company Quarterly Reports On Form , Exchange Commission , Morgan Stanley , Company Or Myriad Genetics , Company Annual Report On Form , Genetics Inc , Wells Fargo Securities , Prospectus Department , Goldman Sachs Co , Myriad Genetics , Securities Litigation , Goldman Sachs , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Nasdaq Mygn , Myriad Genetics ,

Myriad Genetics (NASDAQ:MYGN) Issues FY23 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN – Get Free Report) updated its FY23 earnings guidance on Monday. The company provided EPS guidance of ($0.33)-($0.28) for the period, compared to the consensus EPS estimate of ($0.32). The company issued revenue guidance of $747-$753 million, compared to the consensus revenue estimate of $739.22 million. Myriad Genetics Stock Down 4.0 % […] ....

United States , Richard Bryan Riggsbee , Genetics Inc , Goldman Sachs Group , Securities Exchange Commission , Us Bancorp , Jpmorgan Chase Co , Metlife Investment Management , American Century Companies Inc , Genetics Company Profile , Myriad Genetics , Get Free Report , Genetics Stock Down , Bryan Riggsbee , Exchange Commission , Century Companies , Montreal Can , Life Investment Management , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test , Companion Diagnostic Test , Myriad Genetics Daily , Nasdaq Mygn ,